APOE haplotypes are associated with human longevity in a Central Italy population: Evidence for epistasis with HP 1/2 polymorphism

Clinica Chimica Acta

Volumn 412, Issue 19-20, 2011, Pages 1821-1824

  Napolioni, Valerio ^a   Giannì, Paola ^a   Carpi, Francesco M ^a   Predazzi, Irene M ^b,c   Lucarini, Nazzareno ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Apolipoprotein E; Epistasis; Gene gene interaction; Haptoglobin; Longevity

Indexed keywords

ADULT; AGE; AGED; APOE GENE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HP 1 2 GENE; HUMAN; ITALY; LONGEVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL;

APOLIPOPROTEINS E; BASE SEQUENCE; DNA PRIMERS; EPISTASIS, GENETIC; HAPLOTYPES; HUMANS; ITALY; LONGEVITY; POLYMORPHISM, GENETIC;

EID: 79960650413     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.06.012     Document Type: Article

References (31)

1. Mahley R.W., Rall S.J. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000, 1:507-537.
2. Panza F., D'introno A., Capurso C., et al. Lipoproteins, vascular-related genetic factors, and human longevity. Rejuvenation Res 2007, 10:441-458.
3. Christensen K., Johnson T.E., Vaupel J.W. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet 2006, 7:436-448.
4. GenAge Database 2010, http://genomics.senescence.info/genes/longevity.html.
5. Lewis S.J., Brunner E.J. Methodological problems in genetic association studies of longevity-the apolipoprotein E gene as an example. Int J Epidemiol 2004, 33:962-970.
6. Jazwinski S.M., Kim S., Dai J., et al. HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell 2010, 9:698-708.
7. Napolioni V., Giannì P., Carpi F.M., Concetti F., Lucarini N. Haptoglobin (HP) polymorphisms and human longevity: a cross-sectional association study in a Central Italy population. Clin Chim Acta 2011, 412:574-577.
8. Langlois M.R., Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996, 42:1589-1600.
9. Maeda N., Yang F., Barnett D.R., Bowman B.H., Smithies O. Duplication within the haptoglobin Hp2 gene. Nature 1984, 309:131-135.
10. Braeckman L., De Bacquer D., Delanghe J., Claeys L., De Backer G. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 1999, 143:383-388.
11. Cigliano L., Pugliese C.R., Spagnuolo M.S., Palumbo R., Abrescia P. Haptoglobin binds the antiatherogenic protein apolipoprotein E-impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes. FEBS J 2009, 276:6158-6171.
12. Salvatore A., Cigliano L., Carlucci A., Bucci E.M., Abrescia P. Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid. J Neurochem 2009, 110:255-263.
13. Cavalli-Sforza L.L., Menozzi P., Piazza A. The history and geography of human genes 1994, Princeton University Press, Princeton.
14. Passarino G., Montesanto A., Dato S., et al. Sex and age specificity of susceptibility genes modulating survival at old age. Hum Hered 2006, 62:213-220.
15. Yashin A.I., De Benedictis G., Vaupel J.W., et al. Genes, demography, and life span: the contribution of demographic data in genetic studies on aging and longevity. Am J Hum Genet 1999, 65:1178-1193.
16. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990, 31:545-548.
17. Sing C.F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985, 37:268-285.
18. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988, 8:1-21.
19. Hallman D.M., Boerwinkle E., Saha N., et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991, 49:338-349.
20. Braeckman L., De Bacquer D., Rosseneu M., De Backer G. Apolipoprotein E polymorphism in middle-aged Belgian men. Phenotype distribution and relation to serum lipids and lipoproteins. Atherosclerosis 1996, 120:67-73.
21. Pablos-Méndez A., Mayeux R., Ngai C., Shea S., Berglund L. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Atheroscler Thromb Vasc Biol 1997, 17:3534-3541.
22. Sokal RR, Rohlf JF. Biometry. Freeman, W.H. eds, New York; 1981.
23. Napolioni V. Regarding "Haptoglobin 2-1 phenotype predicts rapid growth of abdominal aortic aneurysms". J Vasc Surg 2011, 53:266-267.
24. Panza F., Solfrizzi V., Torres F., et al. Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett 1999, 277:53-56.
25. Bader G., Zuliani G., Kostner G.M., Fellin R. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians. Gerontology 1998, 44:293-299.
26. Seripa D., Franceschi M., Matera M.G., et al. Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy. J Gerontol A Biol Sci Med Sci 2006, 61:918-923.
27. Dato S., Carotenuto L., De Benedictis G. Genes and longevity: a genetic-demographic approach reveals sex- and age-specific gene effects not shown by the case-control approach (APOE and HSP70.1 loci). Biogerontology 2007, 8:31-41.
28. Levy A.P., Levy J.E., Kalet-Litman S., et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2007, 27:134-140.
29. Brouwers A., Langlois M., Delanghe J., et al. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 2004, 176:189-195.
30. Thornton-Wells T.A., Moore J.J., Haines J.L. Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet 2004, 20:640-647.
31. Flint J., Mackay T.F. Genetic architecture of quantitative traits in mice, flies, and humans. Genome Res 2009, 19:723-733.